Hasty Briefsbeta

Bilingual

A pathogenic Tau mutation drives autophagy-lysosome dysfunction that limits Tau degradation in a model of frontotemporal dementia - PubMed

6 hours ago
  • #Autophagy-Lysosome Pathway
  • #Tauopathy
  • #Frontotemporal Dementia
  • A pathogenic Tau mutation (MAPT p.R406W) disrupts autophagy-lysosome function in human neurons, leading to impaired Tau degradation.
  • Mutant Tau neurons show dysfunctional lysosomes with accumulated Tau, reduced lysosome motility, and impaired autophagosome-lysosome fusion.
  • Pharmacological enhancement of autophagy improves cargo clearance and lowers Tau levels but does not restore lysosomal motility defects.
  • The findings suggest boosting autophagy could help restore Tau homeostasis in tauopathies like frontotemporal dementia.